Cargando…
Genomic Profiling of Patient-Derived Colon Cancer Xenograft Models
Recent evidence suggests that patient derived xenograft (PDX) models can maintain certain pathological and molecular features of the original disease. However, these characterizations are limited to immunohistochemistry or by tissue microarray analysis. We conducted a high-throughput sequencing of p...
Autores principales: | Lee, Won-Suk, Kim, Hye-Youn, Seok, Jae Yeon, Jang, Ho Hee, Park, Yeon Ho, Kim, So-Young, Shin, Dong Bok, Hong, Suntaek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603094/ https://www.ncbi.nlm.nih.gov/pubmed/25526474 http://dx.doi.org/10.1097/MD.0000000000000298 |
Ejemplares similares
-
Targeting the PI3K signaling pathway in KRAS mutant colon cancer
por: Hong, Suntaek, et al.
Publicado: (2015) -
Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model
por: Kim, Hye-Youn, et al.
Publicado: (2016) -
A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016) -
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial
por: Park, Kwonoh, et al.
Publicado: (2023) -
ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy
por: Ryu, Hyewon, et al.
Publicado: (2017)